Please login to the form below

Not currently logged in
Email:
Password:

SMC

This page shows the latest SMC news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: DeepMind and NHS success in AI, Bayer invests in COPD, Alecensa OK in Scotland

Daily Brief: DeepMind and NHS success in AI, Bayer invests in COPD, Alecensa OK in Scotland

The positive decision from the Scottish Medicines Consortium (SMC) was based primarily on the phase III ALEX trial, a head-to-head study in which Alecensa showed significantly superiority compared to ... Novartis’ Zycadia was also recommended by NICE

Latest news

More from news
Approximately 13 fully matching, plus 64 partially matching documents found.

Latest Intelligence

  • Patient involvement in health technology assessment Patient involvement in health technology assessment

    We have developed a Public Involvement Network (PIN) that formalises relationships with each submitting patient group through a registration process to become an SMC Patient Group Partner. ... SMC as a respected partner in developing and shaping all

  • The reality of real-world evidence The reality of real-world evidence

    Zaltrap re-submission to the Scottish Medicines Consortium (SMC) included RWE (pooled data from two open-label, single-arm studies) to demonstrate prolonged safety and QoL benefit.

  • Charting a course for expansion Charting a course for expansion

    The dossiers are going in and the conversations with NICE and the SMC are happening and we're cautiously optimistic.”.

  • Sustainable solutions Sustainable solutions

    This is often most notable when Scotland's SMC takes a different opinion on a new drug from its counterpart for England and Wales, NICE. ... Looking at rulings in the decade to 2010 it found that NICE and the SMC held the same view on the availability of

  • Case study: Treatment guidance Case study: Treatment guidance

    Although NICE and the SMC had given positive opinions, UK experience of mifamurtide was limited.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • Recent approval for your brand from NICE or SMC? Time to rethink your market access

    Scottish cost regulators have approved funding for five new therapies on the NHS, offering new treatment options for a range of conditions. Scottish cost regulators have approved funding for five new therapies on the NHS, offering new treatment

  • OUTiCO

    Recent approval for your brand from NICE or SMC? Time to rethink your market access.

  • YorkTown

    decision makers associated with pharmaceutical and medical device/diagnostics market access and HEOR; Developing and writing single technology appraisals (STA) (pharmaceutical and medical device) for regulatory institutions (NICE, EMA, SMC and

  • The Holistic Approach to Market Access

    and to provide local prescribing audit data for inclusion into NICE and SMC technical appraisals the gaining of which is a key element in gaining regional prescribing uptake.

  • Hayward Medical Communications

    We had expected the worst with SMC but your contacts, knowledge and experience of the process certainly made the difference for us and the rest as we say is history. ... Needless to say that I would have no problem in recommending you to other companies

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics